Oncology Intelligence Digest • July 7, 2026 Oncology Intelligence Digest July 07, 2026 Novartis moves to acquire Myricx Bio for up to $1.5 billion ($1.1… Membership Required You must be a member to access this content. View Membership Levels Already a member? Log in here